SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-044181
Filing Date
2022-04-08
Accepted
2022-04-08 16:00:43
Documents
5
Period of Report
2022-05-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm228771-1_def14a.htm DEF 14A 1097803
2 GRAPHIC tm2110663d2-icon_tick4c.jpg GRAPHIC 706
3 GRAPHIC tm2110663d2-icon_cross4c.jpg GRAPHIC 856
4 GRAPHIC tm228771d1-pc_proxy14clr.jpg GRAPHIC 498942
5 GRAPHIC tm228771d1-pc_proxy24clr.jpg GRAPHIC 454838
  Complete submission text file 0001104659-22-044181.txt   2401844
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39044 | Film No.: 22816918
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences